Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
about
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS)Can new chemical therapies improve the management of multiple sclerosis in children?Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
P2860
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
@en
type
label
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
@en
prefLabel
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
@en
P2093
P2860
P1476
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
@en
P2093
Carmela Leone
Cinzia Caserta
Francesco Patti
P2860
P304
P356
10.1586/14737175.2015.1058162
P577
2015-06-22T00:00:00Z